Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X J Qu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 26, 2021
[Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma]X Gao, Z Li, X Y Shao, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|September 20, 2016
Exploring Northwest China's agricultural water-saving strategy: analysis of water use efficiency based on an SE-DEA model conducted in Xi'an, Shaanxi ProvinceL Mu, L Fang, H Wang, et al.
Drug Discoveries & Therapeutics|April 17, 2012
GMP implementation in China: A double-edged sword for the pharmaceutical industryR Y Gai, X J Qu, H X Lou, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 29, 2009
Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activationJ-L Qu, X-J Qu, M-F Zhao, et al.
Drug Discoveries & Therapeutics|April 17, 2012
Dynamic of modernizing traditional Chinese medicine and the standards system for its developmentR Y Gai, H L Xu, X J Qu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2024
Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trialZ Y Lin, P Zhang, P Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2026
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumorsD Y Ruan, S Y Lin, J J Huang, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 26, 2021
[Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma]X Gao, Z Li, X Y Shao, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|September 20, 2016
Exploring Northwest China's agricultural water-saving strategy: analysis of water use efficiency based on an SE-DEA model conducted in Xi'an, Shaanxi ProvinceL Mu, L Fang, H Wang, et al.
Drug Discoveries & Therapeutics|April 17, 2012
GMP implementation in China: A double-edged sword for the pharmaceutical industryR Y Gai, X J Qu, H X Lou, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 29, 2009
Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activationJ-L Qu, X-J Qu, M-F Zhao, et al.
Drug Discoveries & Therapeutics|April 17, 2012
Dynamic of modernizing traditional Chinese medicine and the standards system for its developmentR Y Gai, H L Xu, X J Qu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2024
Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trialZ Y Lin, P Zhang, P Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2026
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumorsD Y Ruan, S Y Lin, J J Huang, et al.
Pageof 2